Delivery Order SPE2DB20D1109-SPE2DB22FP46K
Award Date 6/21/22
Potential Completion Date 6/22/22
Potential Value $11K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a $3,358.12 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,813,873 units of the drug Micardis HCT 80-25 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the government to efficiently procure a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for $1,491.16. The contract is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a medication, with a completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- The U.S. Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB22FB9F0 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Micardis HCT 80-25 mg tablets. This $20,276.64 firm fixed price delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA to supply pharmaceuticals and medical supplies to support Department of Defense military treatment programs and...
- This federal contract award, valued at $2,298.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Micardis HCT 80-12.5 mg tablets to support military and government healthcare programs. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,234.73 firm fixed price delivery order is for the supply of Micardis HCT 40-12.5 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide MICARDIS HCT 80-25 mg tablet prescriptions. The contract, valued at $1,294.00, has a performance period through March 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, serves as the prime contractor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.87 delivery order contract is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,037.48 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 and with a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- This federal contract award, valued at $3,527.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Micardis HCT 80-25 mg tablets. The contract has an ultimate completion date of January 11, 2022 and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The federal contract award, valued at $2,654.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract with a firm fixed price, and it covers the supply of Micardis HCT 40-12.5 mg tablets for the ultimate completion date of January 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...